Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Nicolas Batty"'
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background Immunotherapies have advanced the treatment of metastatic melanoma; however, they are associated with immune-related toxicities. Patients with pre-existing autoimmune comorbidities are commonly excluded from clinical trials invest
Externí odkaz:
https://doaj.org/article/a7ecd5ff737d4e8cb8179faa213d8f20
Autor:
Nida Z. Naqvi, Nicolas Batty, Grace Chang, Aishwarya Rajagopalan, Ermal Bojdani, Priya Gearin, Lynn E DeLisi, Anderson Chen, Vikram Shankar, Haley V Solomon, William Olcott, Dil Tahera, Alesia A. Cloutier, Fe Erlita D. Festin
Publikováno v:
Psychiatry Research
Highlights • The COVID-19 pandemic has affected the provision of psychiatric care in the US across all settings. • The COVID-19 pandemic has affected the US psychiatry physician by raising personal, financial, and ethical concerns. • The COVID-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b25dc530c3063e86dafc338e7c79c48
https://pubmed.ncbi.nlm.nih.gov/32413707
https://pubmed.ncbi.nlm.nih.gov/32413707
Autor:
Mostafa Fraig, Mary Baum, Yoannis Imbert-Fernandez, Smita Ranjan, Sucheta Telang, Jason Chesney, Nicolas Batty
Publikováno v:
Melanoma Research
Talimogene laherparepvec is a genetically modified herpes simplex virus type 1–based oncolytic immunotherapy for the local treatment of unresectable subcutaneous and nodal tumors in patients with melanoma recurrent after initial surgery. We report
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08fa484e23ec9634c87501a9eac041cd
https://doi.org/10.1097/cmr.0000000000000444
https://doi.org/10.1097/cmr.0000000000000444
Publikováno v:
Endocrine-Related Cancer
We present an updated analysis of lenvatinib in radioiodine-refractory differentiated thyroid cancer (RR-DTC) with new duration of response (DOR) data unavailable for the primary analysis. In this randomized, double-blind, multicenter, placebo-contro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23d30a5cdb9dada6b8146ce94adacedc
http://europepmc.org/articles/PMC5958278
http://europepmc.org/articles/PMC5958278
Autor:
Dionne M. Hines, Nicolas Batty, Qiufei Ma, Zhongyun Zhao, Beth Barber, J. Munakata, Yaozhu Juliette Chen
Publikováno v:
Journal of Dermatological Treatment. 28:549-553
This retrospective analysis of the IMS PharMetrics Plus claims database aimed to describe the current real-world treatment patterns for metastatic melanoma in the USA.Included patients (aged ≥18 years) had ≥1 prescription for ipilimumab, vemurafe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6a5568b8b5326e1cd95180ee7936f09
https://doi.org/10.1080/09546634.2016.1277176
https://doi.org/10.1080/09546634.2016.1277176
Publikováno v:
BMC Cancer
BMC Cancer, Vol 18, Iss 1, Pp 1-9 (2018)
BMC Cancer, Vol 18, Iss 1, Pp 1-9 (2018)
Immunotherapies have advanced the treatment of metastatic melanoma; however, they are associated with immune-related toxicities. Patients with pre-existing autoimmune comorbidities are commonly excluded from clinical trials investigating immunotherap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4213ffeaf714dbbf93beb1fcec80d7c
https://doi.org/10.1186/s12885-018-4051-0
https://doi.org/10.1186/s12885-018-4051-0
Autor:
Eric D. Whitman, Nicolas Batty, Sanjay Awasthi, John Nemunaitis, Christopher Windham, Jose Lutzky, Thomas Amatruda, Gerald Downey, Laura F. Hutchins, Jason Chesney, Russell E. Brown, Brendan D. Curti, Pierre L. Triozzi, Marcus C.B. Tan, Gerald P. Linette
Publikováno v:
Melanoma research. 28(1)
Talimogene laherparepvec is a genetically modified herpes simplex virus-1-based oncolytic immunotherapy for the local treatment of unresectable cutaneous, subcutaneous, and nodal tumors in patients with melanoma recurrence following surgery. We aim t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a3dbcecc18776f023bdcc5b202339e8
https://pubmed.ncbi.nlm.nih.gov/29176501
https://pubmed.ncbi.nlm.nih.gov/29176501
Autor:
Kristopher Attwood, Mathew Valerio, Michael Weinstein, Sana Saif, Iris Alatovic, Anthony Troitino, Eric Murawski, Nicolas Batty, Meir Wetzler, Jonathan Pang, Rohit Sharma, Deepika Narasimha, Mathew Kabalan, David Yi, Yong Yin, Joseph LaPenna, Joseph Shatzel, Samuel Wiles
Publikováno v:
Journal of Cancer Policy. 2:40-44
Background As novel therapies in oncology and in particular hematological malignancies impose a high financial burden with a limited increase in life expectancy. Therefore, CEA is important to evaluate the value of new therapies. However, there is a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71b2a8f8d2f9f9846f59070ccac37481
https://doi.org/10.1016/j.jcpo.2014.01.002
https://doi.org/10.1016/j.jcpo.2014.01.002
Publikováno v:
Cancer Letters. 280:192-200
Histone deacetylase inhibitors (HDACIs) constitute a novel class of targeted drugs that alter the acetylation status of histones and other important cellular proteins. These agents modulate chromatin structure leading to transcriptional changes, indu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d479df5eceaab3a4a866f72a70a30eb
https://doi.org/10.1016/j.canlet.2009.03.013
https://doi.org/10.1016/j.canlet.2009.03.013
Autor:
Eric Raymond, Georges Nicolas Batty, Christophe Le Tourneau, Ghassan El Maalouf, Sandrine Faivre
Publikováno v:
Cancer Treatment Reviews. 35:167-174
Pancreatic cancer retains a poor prognosis among the gastrointestinal cancers and remains a challenge in oncology. In 1997, gemcitabine became the standard of care in metastatic setting. In the last decades, despite a number of clinical trials assess
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3001794e9578296f02abe1d9bc9a73d4
https://doi.org/10.1016/j.ctrv.2008.10.002
https://doi.org/10.1016/j.ctrv.2008.10.002